ArticleInternational urology and nephrology2026
Association of limb ischemic preconditioning with intradialytic hypotension in patients with diabetic kidney disease undergoing hemodialysis: a retrospective analysis.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the association between limb ischemic preconditioning (LIPC) and intradialytic hypotension (IDH) in patients with diabetic kidney disease (DKD) undergoing maintenance hemodialysis (MHD).
methodsThis single-center retrospective cohort study consecutively enrolled 112 patients with DKD receiving MHD at our institution between January and December 2023. Among them, 50 patients were assigned to the LIPC group and 62 to the control group. The incidence of IDH, blood pressure trends, clinical interventions, and the occurrence of major adverse cardiovascular events (MACE) were compared between groups. Considering the potential intra-individual correlation across repeated dialysis sessions, a generalized linear mixed model (GLMM) was used to identify independent risk factors for IDH, with each dialysis session as the unit of analysis and patient-specific random intercepts included.
resultsThe overall incidence of IDH in the LIPC group was 7.1% (4.7-8.8), significantly lower than 11.8% (6.6-30.0) in the control group. The frequency of IDH episodes across all time intervals (0-1 h, 1-2 h, 2-3 h, and 3-4 h) was significantly lower in the LIPC group (all P < 0.001). The reduction in systolic blood pressure was smaller in the LIPC group compared with the control group (11.2 mmHg vs. 21.4 mmHg). LIPC (odds ratio [OR] = 0.39, 95% confidence interval [CI]: 0.28-0.54) and baseline systolic blood pressure (OR = 0.98, 95% CI: 0.97-1.00) were protective factors for IDH.
conclusionsLIPC use was associated with a significantly lower incidence of IDH in DKD patients undergoing MHD and attenuated blood pressure decline, with a favorable safety profile.
Indexed as
Identifiers
42814198What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.